TEM Tempus AI, Inc.
Company Analysis
Latest News
🟢 Tempus AI is trading 4.1% up today after $192.5 million agreements
Tempus AI is trading 4.09% up at $66.42, with the gain accompanying its October 23 announcement of agreements with Bristol Myers Squibb and Pathos AI. - The...
Tempus AI Announces $192.5M Data Licensing Agreements with Bristol-Myers Squibb and Pathos AI
Tempus AI has entered into a series of agreements with Bristol-Myers Squibb (BMS) and Pathos AI to expand the use of its de-identified multimodal real-world...
🔴 Tempus AI is trading 4.67% down today amid AI infrastructure spending concerns
Tempus AI is trading at $64.59, down 4.67%, amid broader risk-off pressure on technology and AI-linked stocks. - Investors are questioning AI infrastructure...
🟢 Tempus AI is trading 4.3% up today
Tempus AI is trading at $67.08, up 4.26% during the October 20 session; no reliable report identified a specific catalyst. - On October 19, Tempus AI...
Tempus AI Presents Positive Data on AI Pre-Screening for Lung Cancer
Tempus AI announced positive results from a large study. The study focused on its AI-enabled pre-screening panel for advanced non-small cell lung cancer...
Tempus AI Highlighted as a Top Q3 Performer by Cathie Wood's Ark Invest
Ark Invest's third-quarter report highlighted Tempus AI as a standout performer. Tempus AI contributed 3.21 percentage points to the ARK Genomic Revolution ETF...
🔴 Tempus AI is trading 4.3% down today amid broader AI-stock pressure and rate concerns
Tempus AI is trading at $68.11, down 4.25% at 9:50 a.m. Eastern on October 16, 2026, amid broader pressure on AI-related stocks; no clear company-specific...
🟢 Tempus AI is trading 4.7% up with no clear company-specific catalyst
Tempus AI is trading at $71.51, up +4.67%, with no clearly reported company-specific catalyst for the October 15 gain. - The highlighted Moderna/Merck...
🔴 Tempus AI is trading 4.5% down in pre-market amid broad technology and market pressure
Tempus AI is trading at $65.24, down 4.50% in pre-market amid broad technology and market pressure. - No new company-specific catalyst surfaced; its latest...
🔴 Tempus AI is trading 4.04% down — catalyst remains unclear
Tempus AI is trading 4.04% lower at $68.06, with the October 12 decline’s cause unclear. - No clear company-specific announcement or other catalyst surfaced in...
🟢 Tempus AI is trading 5% up with no clear catalyst identified
Tempus AI is trading 4.76% higher at $72.58 on October 9, 2026, with no specific intraday catalyst established by available evidence. - Recent coverage points...
🔴 Tempus AI is trading 4.9% down with no clear company-specific catalyst
Tempus AI is trading 4.9% lower at $66.92; no clear company-specific announcement or catalyst explaining the October 8 decline surfaced in available...
Tempus Expands Moderna-Merck Collaboration for Potential Cancer Therapy Launch
Tempus AI has expanded its multi-year collaboration with Moderna and Merck to support the potential commercialization of intismeran autogene (V940/mRNA-4157),...
🔴 Tempus AI is trading 10% down
Tempus AI is trading at $75.17, down -10.03%, with no clear company-specific catalyst for the October 6 decline confirmed in available reporting. - Broader...
🔴 Tempus AI is trading 4.74% down
Tempus AI is trading at $79.59, down 4.74%, with no clear company-specific catalyst confirmed for the October 6 decline. - FDA clearance for its ECG-MR...
🟢 Tempus AI is trading 4.3% up today — no specific catalyst confirmed
Tempus AI is trading up 4.34% at $87.18; no specific reason is confirmed. - In the prior session, shares rose 9.03% to close at $83.55. - An October 6 report...
🟢 Tempus AI is trading 4.35% up
Tempus AI is trading 4.35% up at $79.96 on October 5; no company-specific announcement dated October 5 was found to explain the move. - The latest listed...
Tempus AI Updates Personalis Merger Filing, Details $48.42 Price Floor
Tempus AI filed an amended Form S-4/A with the SEC on October 2, 2026, providing updated details on its pending acquisition of Personalis, Inc. Under the...
🟢 Tempus AI is trading 4.45% up today as weak payrolls ease rate-hike expectations
Tempus AI is trading at $79.91, up 4.45%, alongside a broader risk-on rally after September payrolls rose by just 29,000 and rate-hike expectations eased. -...
🔴 Tempus AI is trading 4% down today as Treasury yields weigh on markets
Tempus AI is trading 4.02% lower at $78.61 as rising Treasury yields weigh on markets, though no company-specific announcement clearly explains the decline. -...